Laurent Humeau
Chief Tech/Sci/R&D Officer en INOVIO PHARMACEUTICALS, INC. .
Fortuna: 295 214 $ al 31/03/2024
Cargos activos de Laurent Humeau
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/02/2014 | - |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Director/Board Member | 12/10/2022 | - |
Historial de carrera de Laurent Humeau
Antiguos cargos conocidos de Laurent Humeau.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 01/01/2000 | - |
Formación de Laurent Humeau.
Estadísticas
Internacional
| Estados Unidos | 5 |
| Francia | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
| Université Paris Diderot-Paris 7 | Consumer Services |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Laurent Humeau
- Experiencia
